EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear and consensual international recommendations on RA treatment are not available. In this paper recommendations for the treatment of RA with synthetic and biological disease-modifying antirheumatic drugs (DMAR...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Smolen, Josef S, Landewé, Robert, Breedveld, Ferdinand C, Dougados, Maxime, Emery, Paul, Gaujoux-Viala, Cecile, Gorter, Simone, Knevel, Rachel, Nam, Jackie, Schoels, Monika, Aletaha, Daniel, Buch, Maya, Gossec, Laure, Huizinga, Tom, Bijlsma, Johannes W J W, Burmester, Gerd, Combe, Bernard, Cutolo, Maurizio, Gabay, Cem, Gomez-Reino, Juan, Kouloumas, Marios, Kvien, Tore K, Martin-Mola, Emilio, McInnes, Iain, Pavelka, Karel, van Riel, Piet, Scholte, Marieke, Scott, David L, Sokka, Tuulikki, Valesini, Guido, van Vollenhoven, Ronald, Winthrop, Kevin L, Wong, John, Zink, Angela, van der Heijde, Désirée
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Group 2010
Materias:
Recommendations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2935329/
https://ncbi.nlm.nih.gov/pubmed/20444750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2009.126532
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares